In Reply We thank Luo et al for their interest in soluble urokinase plasminogen activator receptor (suPAR), as discussed in our article.1 Soluble urokinase plasminogen activator receptor is associated with chronic conditions, as revealed in many prior reports of midlife to older adults.2-6
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Rasmussen LJH, Moffitt TE, Caspi A. Major Concerns Over Improving Measurement of Inflammation Remain—Reply. JAMA Pediatr. 2020;174(6):624–625. doi:10.1001/jamapediatrics.2020.0291
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: